drugset / Trial / NCT00751413
Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)
RandomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the safety, tolerability and plasma levels of single oral doses of MK0633 in pediatric asthma patients ages 6 to less than 12 years.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SETILEUTON | Small molecule | 10 mg | Oral |
| Subject | SETILEUTON | Small molecule | 25 mg | Oral |